Innate Pharma SA (IPHYF)
2.13
-0.52
(-19.62%)
USD |
OTCM |
May 03, 16:00
Innate Pharma Price: 2.13 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 2.13 | 2.13 | 2.13 | 2.13 | 2000.00 |
May 02, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
May 01, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 30, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 29, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 26, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 25, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 24, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 23, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 22, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 19, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 18, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 17, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 16, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 15, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 12, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 11, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 10, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 09, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 08, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 05, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 04, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 03, 2024 | 2.65 | 2.65 | 2.65 | 2.65 | 0.000 |
Apr 02, 2024 | 2.43 | 2.65 | 2.43 | 2.65 | 300.00 |
Apr 01, 2024 | 2.58 | 2.58 | 2.58 | 2.58 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.93
Minimum
Sep 29 2022
8.08
Maximum
Sep 27 2019
4.290
Average
3.765
Median
Oct 01 2020
Price Benchmarks
DBV Technologies SA | 0.6669 |
Cellectis SA | 2.99 |
PHAXIAM Therapeutics SA (DELISTED) | 3.10 |
Genfit SA | 3.66 |
Price Related Metrics
PS Ratio | 3.04 |
Price to Book Value | 3.001 |
Earnings Yield | -4.54% |
Market Cap | 172.19M |